Related Experiment Video
Updated: Mar 1, 2026

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
Published on: November 25, 2012
Screening, genetics, risk factors, and treatment of neonatal cataracts
Jinyu Li1,2, Chun-Hong Xia3, Eddie Wang3
1Eye Center, Second Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, China.
Insights
Congenital cataracts are a leading cause of childhood vision loss. Advances in genetics and surgery improve diagnosis and treatment, yet more research is needed for unknown causes and optimal outcomes.
Area of Science:
- Ophthalmology
- Genetics
- Pediatrics
Background:
- Neonatal cataracts are the primary cause of pediatric visual impairment globally.
- Etiologies are diverse and often remain unidentified.
- Significant progress has been made in understanding congenital cataracts.
Purpose of the Study:
- To review current knowledge on congenital cataract detection, treatment, genetics, risk factors, and molecular mechanisms.
- To highlight advancements and identify areas for future research in clinical and basic lens science.
Main Methods:
- Literature review of congenital cataract research.
- Synthesis of information on genetic screening, surgical technologies, and molecular mechanisms.
- Analysis of diagnostic criteria and intervention strategies.
Main Results:
- Genetic screening and surgical advancements have improved diagnosis, management, and visual outcomes.
- Known mutations in lens crystallins and membrane/cytoskeletal components underlie inherited cataracts.
- Many etiological factors, progression patterns, and pathologies require further investigation.
Conclusions:
- Further research is essential to elucidate unknown causes and improve understanding of neonatal cataract pathology.
- Enhanced diagnostic criteria are needed for timely interventions, including intraocular lens implantation and postoperative care.
- Optimizing surgical and management strategies is crucial for ensuring safe and predictable visual outcomes in children.
Abstract:
Neonatal cataracts remain the most common cause of visual loss in children worldwide and have diverse, often unknown, etiologies. This review summarizes current knowledge about the detection, treatment, genetics, risk factors, and molecular mechanisms of congenital cataracts. We emphasize significant progress and topics requiring further study in both clinical cataract therapy and basic lens research. Advances in genetic screening and surgical technologies have improved the diagnosis, management, and visual outcomes of affected children. For example, mutations in lens crystallins and membrane/cytoskeletal components that commonly underlie genetically inherited cataracts are now known. However, many questions still remain regarding the causes, progression, and pathology of neonatal cataracts. Further investigations are also required to improve diagnostic criteria for determining the timing of appropriate interventions, such as the implantation of intraocular lenses and postoperative management strategies, to ensure safety and predictable visual outcomes for children. Birth Defects Research 109:734-743, 2017. © 2017 Wiley Periodicals, Inc.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
10:32Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...